CLINICAL_TRIALS
trial_result
· 2021-09-28
Clinical Trial Update: Clearance of 25-hydroxyvitamin D3 During Vitamin D3 Supplementation [Phase 1]
Summary
Phase 1 trial assessing clearance of 25-hydroxyvitamin D3 during Vitamin D3 supplementation in adults with chronic kidney disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Washington | Conditions: Chronic Kidney Disease | Phase 1 | Status: COMPLETED | Results posted: 2021-09-28